161 related articles for article (PubMed ID: 22302563)
1. Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz.
Kromdijk W; Mulder JW; Rosing H; Smit PM; Beijnen JH; Huitema AD
J Antimicrob Chemother; 2012 May; 67(5):1211-6. PubMed ID: 22302563
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study.
Manosuthi W; Sungkanuparph S; Tantanathip P; Lueangniyomkul A; Mankatitham W; Prasithsirskul W; Burapatarawong S; Thongyen S; Likanonsakul S; Thawornwa U; Prommool V; Ruxrungtham K;
Clin Infect Dis; 2009 Jun; 48(12):1752-9. PubMed ID: 19438397
[TBL] [Abstract][Full Text] [Related]
3. Effect of anticoagulants on plasma nevirapine and efavirenz concentrations.
Hemanth Kumar AK; Ramachandran G; Kumar P; Anitha S; Rajasekaran S; Swaminathan S
Ther Drug Monit; 2007 Oct; 29(5):652-4. PubMed ID: 17898659
[TBL] [Abstract][Full Text] [Related]
4. Using dried blood spots to facilitate therapeutic drug monitoring of antiretroviral drugs in resource-poor regions.
Duthaler U; Berger B; Erb S; Battegay M; Letang E; Gaugler S; Natamatungiro A; Mnzava D; Donzelli M; Krähenbühl S; Haschke M
J Antimicrob Chemother; 2018 Oct; 73(10):2729-2737. PubMed ID: 30052975
[TBL] [Abstract][Full Text] [Related]
5. Dried plasma/blood spots for monitoring antiretroviral treatment efficacy and pharmacokinetics: a cross-sectional study in rural Burundi.
Calcagno A; Motta I; Milia MG; Rostagno R; Simiele M; Libanore V; Fontana S; D'Avolio A; Ghisetti V; Di Perri G; Bonora S
Br J Clin Pharmacol; 2015 May; 79(5):801-8. PubMed ID: 25377591
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of efavirenz are associated with body weight in HIV-positive individuals.
Poeta J; Linden R; Antunes MV; Real L; Menezes AM; Ribeiro JP; Sprinz E
J Antimicrob Chemother; 2011 Nov; 66(11):2601-4. PubMed ID: 21890538
[TBL] [Abstract][Full Text] [Related]
7. Nevirapine and efavirenz pharmacokinetics and covariate analysis in the 2NN study.
Kappelhoff BS; van Leth F; MacGregor TR; Lange J; Beijnen JH; Huitema AD;
Antivir Ther; 2005; 10(1):145-55. PubMed ID: 15751772
[TBL] [Abstract][Full Text] [Related]
8. Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy.
Rottinghaus EK; Ugbena R; Diallo K; Bassey O; Azeez A; Devos J; Zhang G; Aberle-Grasse J; Nkengasong J; Yang C
Clin Infect Dis; 2012 Apr; 54(8):1187-95. PubMed ID: 22412066
[TBL] [Abstract][Full Text] [Related]
9. A validated method for simultaneous quantification of four antiretrovirals in dried blood spot and plasma using LC-MS/MS: Application to efavirenz therapeutic drug monitoring in pregnant patients.
Ludna Duarte M; Mikaelle Brandão Silva A; Wellithom Viturino da Silva J; Pereira Santana D; Victor de Castro W; Cláudio Arraes de Alencar L; César Galindo Bedor D; Bastos Leal L
Clin Biochem; 2024 May; 127-128():110765. PubMed ID: 38649089
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Dried Blood Spots Versus Conventional Plasma Collection for the Characterization of Efavirenz Pharmacokinetics in a Large-Scale Global Clinical Trial-The ENCORE1 Study.
Amara AB; Else LJ; Carey D; Khoo S; Back DJ; Amin J; Emery S; Puls RL
Ther Drug Monit; 2017 Dec; 39(6):654-658. PubMed ID: 28953037
[TBL] [Abstract][Full Text] [Related]
11. Antiviral efficacy, tolerability and pharmacokinetics of efavirenz in an unselected cohort of HIV-infected children.
Wintergerst U; Hoffmann F; Jansson A; Notheis G; Huss K; Kurowski M; Burger D
J Antimicrob Chemother; 2008 Jun; 61(6):1336-9. PubMed ID: 18343800
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of saliva as an alternative matrix for monitoring plasma Zidovudine, Lamivudine and nevirapine concentrations in Rwanda.
Gras A; Schneider S; Karasi JC; Ternes AM; Sauvageot N; Karasi-Omes C; Henry AP; Schmit JC; Seguin-Devaux C; Arendt V
Curr HIV Res; 2011 Jun; 9(4):223-8. PubMed ID: 21671885
[TBL] [Abstract][Full Text] [Related]
13. Intra-individual variability in efavirenz plasma concentrations supports therapeutic drug monitoring based on quarterly sampling in the first year of therapy.
Pereira SA; Branco T; Caixas U; Côrte-Real RM; Germano I; Lampreia F; Monteiro EC
Ther Drug Monit; 2008 Feb; 30(1):60-6. PubMed ID: 18223464
[TBL] [Abstract][Full Text] [Related]
14. Automated high throughput analysis of antiretroviral drugs in dried blood spots.
Duthaler U; Berger B; Erb S; Battegay M; Letang E; Gaugler S; Krähenbühl S; Haschke M
J Mass Spectrom; 2017 Aug; 52(8):534-542. PubMed ID: 28557187
[TBL] [Abstract][Full Text] [Related]
15. Influence of liver fibrosis stage on plasma levels of efavirenz in HIV-infected patients with chronic hepatitis B or C.
Meynard JL; Lacombe K; Poirier JM; Legrand J; Morand-Joubert L; Girard PM
J Antimicrob Chemother; 2009 Mar; 63(3):579-84. PubMed ID: 19168543
[TBL] [Abstract][Full Text] [Related]
16. Comparative biological and clinical outcomes after a switch from a virologically unsuccessful first protease inhibitor-containing antiretroviral combination to a 3-drug regimen containing efavirenz, nevirapine, or abacavir.
Abgrall S; Yeni PG; Bouchaud O; Costagliola D;
Clin Infect Dis; 2007 Jan; 44(1):120-7. PubMed ID: 17143827
[TBL] [Abstract][Full Text] [Related]
17. Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices.
Calcagno A; D'Avolio A; Simiele M; Cusato J; Rostagno R; Libanore V; Baietto L; Siccardi M; Bonora S; Di Perri G
Br J Clin Pharmacol; 2012 Jul; 74(1):134-40. PubMed ID: 22680342
[TBL] [Abstract][Full Text] [Related]
18. Nevirapine concentration in nonstimulated saliva: an alternative to plasma sampling in children with human immunodeficiency virus infection.
Rakhmanina NY; Capparelli EV; van den Anker JN; Williams K; Sever JL; Spiegel HM; Soldin SJ
Ther Drug Monit; 2007 Feb; 29(1):110-7. PubMed ID: 17304158
[TBL] [Abstract][Full Text] [Related]
19. The steady-state pharmacokinetics of efavirenz and nevirapine when used in combination in human immunodeficiency virus type 1-infected persons.
Veldkamp AI; Harris M; Montaner JS; Moyle G; Gazzard B; Youle M; Johnson M; Kwakkelstein MO; Carlier H; van Leeuwen R; Beijnen JH; Lange JM; Reiss P; Hoetelmans RM
J Infect Dis; 2001 Jul; 184(1):37-42. PubMed ID: 11398107
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring of antiretroviral drugs at home using dried blood spots: a proof-of-concept study.
Kromdijk W; Mulder JW; Smit PM; Ter Heine R; Beijnen JH; Huitema AD
Antivir Ther; 2013; 18(6):821-5. PubMed ID: 23234680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
